ALMKT Stock Overview
A medical device company, manufactures and sells medical devices in Europe and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Mauna Kea Technologies SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.43 |
52 Week High | €0.69 |
52 Week Low | €0.34 |
Beta | 1.36 |
1 Month Change | 6.90% |
3 Month Change | 1.52% |
1 Year Change | -31.33% |
3 Year Change | -62.00% |
5 Year Change | -73.11% |
Change since IPO | -96.62% |
Recent News & Updates
Shareholder Returns
ALMKT | FR Medical Equipment | FR Market | |
---|---|---|---|
7D | 3.6% | 2.3% | 1.4% |
1Y | -31.3% | 21.1% | 7.3% |
Return vs Industry: ALMKT underperformed the French Medical Equipment industry which returned 21.1% over the past year.
Return vs Market: ALMKT underperformed the French Market which returned 7.3% over the past year.
Price Volatility
ALMKT volatility | |
---|---|
ALMKT Average Weekly Movement | 6.2% |
Medical Equipment Industry Average Movement | 5.1% |
Market Average Movement | 4.4% |
10% most volatile stocks in FR Market | 9.5% |
10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALMKT has not had significant price volatility in the past 3 months.
Volatility Over Time: ALMKT's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 68 | Sacha Loiseau | www.maunakeatech.com |
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions.
Mauna Kea Technologies SA Fundamentals Summary
ALMKT fundamental statistics | |
---|---|
Market cap | €26.96m |
Earnings (TTM) | -€3.73m |
Revenue (TTM) | €11.03m |
2.4x
P/S Ratio-7.2x
P/E RatioIs ALMKT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALMKT income statement (TTM) | |
---|---|
Revenue | €11.03m |
Cost of Revenue | €2.10m |
Gross Profit | €8.93m |
Other Expenses | €12.66m |
Earnings | -€3.73m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 26, 2024
Earnings per share (EPS) | -0.06 |
Gross Margin | 80.98% |
Net Profit Margin | -33.80% |
Debt/Equity Ratio | -169.3% |
How did ALMKT perform over the long term?
See historical performance and comparison